Miranda-COPD

  • Study Sponsor and Protocol Number: 
    AstraZeneca (D9180C00012)
  • Specialty:
    Pulmonology
  • Type:
    Investigational Drug
  • Inclusion:
    Age 40+
    Former smoker with 10 pack year history
    2 moderate or 1 severe COPD exacerbation in the last 12 months
    ICS/LABA/LAMA dual or triple therapy
  • Exclusion:
    Asthma

    •